Literature DB >> 23201057

Treatment of hemimandibular paresthesia in a patient with bisphosphonate-related osteonecrosis of the jaw (BRONJ) by combining surgical resection and PRGF-Endoret.

E Anitua1, L Begoña, G Orive.   

Abstract

We report a case of a 50-year-old patient with bisphosphonate-related osteonecrosis of the jaws (BRONJs) whose symptoms included severe pain and hemimandibular paraesthesia. The treatment included resection of necrotic bone and the application of plasma rich in growth factors (PRGF(®)-Endoret(®)). We closed the ulcer in the soft tissue and her pain and paraesthesia improved. One year postoperatively sensitivity was totally recovered, pain was absent and bone was partially regenerated.
Copyright © 2012 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRONJ; Bisphosphonates; Osteonecrosis; PRGF; Paresthesia; Platelet rich plasma

Mesh：

Year:  2012        PMID： 23201057     DOI： 10.1016/j.bjoms.2012.08.018

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN： 0266-4356            Impact factor:   1.651


  8 in total

1.  PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.

Authors:  Eduardo Anitua; Mar Zalduendo; María Troya; Gorka Orive
Journal:  Clin Oral Investig       Date:  2015-07-23       Impact factor: 3.573

2.  The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.

Authors:  Olga Di Fede; Federica Canepa; Vera Panzarella; Rodolfo Mauceri; Carmine Del Gaizo; Alberto Bedogni; Vittorio Fusco; Pietro Tozzo; Giuseppe Pizzo; Giuseppina Campisi; Antonio Galvano
Journal:  Int J Environ Res Public Health       Date:  2021-08-10       Impact factor: 3.390

Review 3.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11

4.  Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide.

Authors:  Alejandro Pelaz; Luis Junquera; Lorena Gallego; Luis García-Consuegra; Sonsoles Junquera; Carlos Gómez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-07-01

Review 5.  Platelet-rich plasma for regeneration of neural feedback pathways around dental implants: a concise review and outlook on future possibilities.

Authors:  Yan Huang; Michael M Bornstein; Ivo Lambrichts; Hai-Yang Yu; Constantinus Politis; Reinhilde Jacobs
Journal:  Int J Oral Sci       Date:  2017-03-10       Impact factor: 6.344

6.  Three-dimensional bone evaluation after surgical treatment with plasma rich in growth factors of Medication Related Osteonecrosis of the Jaw (MRONJ): A report of 3 cases.

Authors:  Simón Pardiñas López; Oreste Iocca; Ismael Khouly
Journal:  Bone Rep       Date:  2019-05-03

7.  Autologous Platelet Rich Plasma (PRGF) Preserves Genomic Stability of Gingival Fibroblasts and Alveolar Osteoblasts after Long-Term Cell Culture.

Authors:  Eduardo Anitua; María de la Fuente; María Troya; Mar Zalduendo; Mohammad Hamdan Alkhraisat
Journal:  Dent J (Basel)       Date:  2022-09-14

8.  An Autologous Topical Serum Derived from Platelet-Rich Plasma Therapy for the Management of Sensitive Skin Alterations: A Case Series Report.

Authors:  Cristina García-Millan; Ander Pino; Rita Rodrigues; Gonzalo Segurado-Miravalles; Adrián Alegre-Sánchez; Pedro Jaén; Eduardo Anitua
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.